Publicaciones en colaboración con investigadores/as de Complejo Asistencial de Ávila (34)

2023

  1. Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain

    European Journal of Haematology, Vol. 111, Núm. 3, pp. 485-490

2022

  1. Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study

    Medicine (United States), Vol. 101, Núm. 24, pp. E29252

  2. Juntos Ante el Peligro: Resultados de traquetomías para pacientes críticos por COVID-19, unidades multicéntricas de ORL en Castilla y León: Estudio de cohortes de más de 139 pacientes críticos COVD-19

    Revista ORL, Vol. 13, Núm. 2, pp. 65-66

  3. Uroflujometría en el adulto

    FMC: Formación Médica Continuada en Atención Primaria, Vol. 29, Núm. 7, pp. 371-374

  4. Usefulness of the 5MPB-Toledo model to predict bacteremia in the elderly patient

    Infectio, Vol. 26, Núm. 2, pp. 128-136

2021

  1. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation

    BMC Cardiovascular Disorders, Vol. 21, Núm. 1

  2. Effect of the type of specialized nutrition support on the course of the patient with amyotrophic lateral sclerosis (ALS). Interhospital registry SCLEDyN

    Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 10, pp. 699-707

  3. Incidence, characteristics and clinical profile of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with pre-existing primary immune thrombocytopenia (ITP) in Spain

    British Journal of Haematology, Vol. 194, Núm. 3, pp. 537-541

  4. Traumatismos genitourinarios y del aparato urinario inferior y del aparato genital masculino

    Nefrología y urología (Ediciones Universidad de Salamanca), pp. 361-369

  5. Traumatismos genitourinarios y del aparato urinario superior

    Nefrología y urología (Ediciones Universidad de Salamanca), pp. 351-360

2020

  1. A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma

    American Journal of Hematology, Vol. 95, Núm. 5, pp. 503-509

  2. Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients

    Leukemia and Lymphoma, Vol. 61, Núm. 8, pp. 1885-1893

  3. Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia

    European Journal of Haematology, Vol. 104, Núm. 3, pp. 259-270

2019

  1. Blood monitoring of circulating tumor plasma cells by next generation flow in multiple myeloma after therapy

    Blood

2017

  1. Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice

    International Journal of Hematology, Vol. 106, Núm. 4, pp. 508-516

  2. Prognostic accuracy of SIRS criteria, qSOFA score and GYM score for 30-day-mortality in older non-severely dependent infected patients attended in the emergency department

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 12, pp. 2361-2369

  3. Use of eltrombopag for secondary immune thrombocytopenia in clinical practice

    British Journal of Haematology, Vol. 178, Núm. 6, pp. 959-970

2016

  1. Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice

    European Journal of Haematology, Vol. 97, Núm. 3, pp. 297-302

  2. Síndrome de Turner: análisis de 42 casos

    Medicina Clinica, Vol. 147, Núm. 8, pp. 348-351

  3. Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients

    Journal of Aerosol Medicine and Pulmonary Drug Delivery, Vol. 29, Núm. 2, pp. 142-152